Clinical consequences of delaying implementation of long-acting antiretroviral therapy for people with HIV and persistent viremia in the US

By afschroeder • August 5, 2025

Pei PP, Jones M, Hu R, Chen W, Sax PE, Pandya A, Gandhi M, Eron JJ, Currier JS, Wilkin TJ, Reddy KP, Qoshe L, Hyle EP, Freedberg KA. Clinical consequences of delaying implementation of long-acting antiretroviral therapy for people with HIV and persistent viremia in the US. Clin Infect Dis. 2025 Aug 4:ciaf428. doi: 10.1093/cid/ciaf428. Epub ahead of print. PMID: 40757869.

Tags: clinical trials, HIV, Implementation, Infectious Diseases, long-acting antiretrovirals, Publications, resistance

Prevalence, characteristics, and clinical course of mpox-related ophthalmic disease (MBOTE-EYE): a prospective cohort study in South Kivu, Democratic Republic of the Congo

Kabesha T, Van Dijck C, Mudwanga S, Houben S, Mujula Y, Munganga P, Tshomba JC, Mukari G, Wawina-Bokalanga T, Kinganda-Lusamaki E, Jacobs BK, Tsoumanis A,[...]

Determinants of PrEP Delivery Platform Choice in Adolescents and Young People: The Fast-PrEP Project in Cape Town, South Africa

Rousseau E, Bondarchuk C, Lebelo K, Matsebula L, Bennin F, Macdonald P, Pike C, Vanto O, Mathole N, Fynn L, Davey DJ, Coakley C, Wallace[...]

Proteomic Immune Signatures of Severe HIV-Associated Tuberculosis in Sub-Saharan Africa: A Prospective, Multicenter Analysis From Uganda

Ross JE, Tomoiaga AS, Owor N, Lu X, Shinyale J, Kiyingi T, Asasira I, Eliku PJ, Nsubuga JB, Nsereko C, Nayiga I, Kyebambe S, Ochar[...]